药品名称 | VIRAMUNE | 申请号 | 020636 | 产品号 | 001 | 活性成分 | NEVIRAPINE | 市场状态 | 处方药 | 剂型或给药途径 | TABLET;ORAL | 规格 | 200MG | 治疗等效代码 | AB | 参比药物 | 是 | 批准日期 | 1996/06/21 | 申请机构 | BOEHRINGER INGELHEIM PHARMACEUTICALS INC
| 化学类型 | New molecular entity (NME) | 审评分类 | Priority review drug |
|
|
|
与本品相关的市场独占权保护信息 | 独占权代码 | 失效日期 | 无 | 历史市场独占权保护信息 | 无 |
|
与药品注册相关的信息 | 申请号 | 修订号 | 审批结论 | 公开文档类型 | 文档创建时间 | 获取文档 | 020636 | 044 | AP | Letter | 2014/01/28 | 下载 | 020636 | 044 | AP | Label | 2014/01/28 | 下载 | 020636 | 042 | AP | Letter | 2012/11/13 | 下载 | 020636 | 042 | AP | Medication Guide | 2012/11/15 | 下载 | 020636 | 042 | AP | Label | 2012/11/15 | 下载 | 020636 | 039 | AP | Label | 2011/11/10 | 下载 | 020636 | 039 | AP | Letter | 2011/11/14 | 下载 | 020636 | 038 | AP | Letter | 2011/05/10 | 下载 | 020636 | 037 | AP | Label | 2011/03/28 | 下载 | 020636 | 037 | AP | Letter | 2011/03/31 | 下载 | 020636 | 036 | AP | Label | 2011/01/10 | 下载 | 020636 | 036 | AP | Letter | 2011/01/14 | 下载 | 020636 | 035 | AP | Label | 2010/07/22 | 下载 | 020636 | 035 | AP | Letter | 2010/07/23 | 下载 | 020636 | 032 | AP | Label | 2010/01/20 | 下载 | 020636 | 032 | AP | Letter | 2010/01/26 | 下载 | 020636 | 029 | AP | Label | 2007/08/17 | 下载 | 020636 | 029 | AP | Letter | 2007/08/17 | 下载 | 020636 | 027 | AP | Label | 2008/06/26 | 下载 | 020636 | 027 | AP | Letter | 2008/06/30 | 下载 | 020636 | 026 | AP | Letter | 2007/04/20 | 下载 | 020636 | 026 | AP | Label | 2007/04/20 | 下载 | 020636 | 025 | AP | Review | 2007/08/06 | 下载 | 020636 | 025 | AP | Label | 2005/03/02 | 下载 | 020636 | 025 | AP | Letter | 2005/03/02 | 下载 | 020636 | 022 | AP | Letter | 2004/05/26 | 下载 | 020636 | 022 | AP | Label | 2004/05/27 | 下载 | 020636 | 021 | AP | Letter | 2003/12/23 | 下载 | 020636 | 021 | AP | Label | 2003/12/29 | 下载 | 020636 | 020 | AP | Letter | 2003/08/06 | 下载 | 020636 | 020 | AP | Label | 2003/08/06 | 下载 | 020636 | 017 | AP | Letter | 2002/03/27 | 下载 | 020636 | 017 | AP | Review | 2005/04/27 | 下载 | 020636 | 016 | AP | Label | 2003/04/04 | 下载 | 020636 | 016 | AP | Letter | 2004/06/30 | 下载 | 020636 | 012 | AP | Review | 2007/08/06 | 下载 | 020636 | 009 | AP | Label | 2004/06/30 | 下载 | 020636 | 009 | AP | Letter | 2004/06/30 | 下载 | 020636 | 009 | AP | Review | 2004/02/04 | 下载 | 020636 | 007 | AP | Review | 2007/08/06 | 下载 | 020636 | 005 | AP | Review | 2007/08/06 | 下载 | 020636 | 002 | AP | Review | 2007/08/06 | 下载 | 020636 | 000 | AP | Medication Guide | 2007/02/22 | 下载 |
|
药品注册审批历史信息 | 申请号 | 修订号 | 审批结论 | 审批日期 | 审批内容 | 020636 | 047 | AP | 2016/04/14 | Manufacturing Change or Addition | 020636 | 044 | AP | 2014/01/27 | Labeling Revision | 020636 | 042 | AP | 2012/11/09 | Labeling Revision | 020636 | 039 | AP | 2011/11/09 | Labeling Revision | 020636 | 038 | AP | 2011/05/06 | Labeling Revision | 020636 | 037 | AP | 2011/03/25 | Labeling Revision | 020636 | 036 | AP | 2011/01/07 | Labeling Revision | 020636 | 035 | AP | 2010/07/20 | Labeling Revision | 020636 | 032 | AP | 2010/01/13 | Labeling Revision | 020636 | 029 | AP | 2007/08/16 | Labeling Revision | 020636 | 027 | AP | 2008/06/24 | Patient Population Altered | 020636 | 026 | AP | 2007/04/13 | Labeling Revision | 020636 | 025 | AP | 2005/02/24 | Labeling Revision | 020636 | 022 | AP | 2004/05/24 | Labeling Revision | 020636 | 021 | AP | 2003/12/22 | Labeling Revision | 020636 | 020 | AP | 2003/07/29 | Labeling Revision | 020636 | 019 | AP | 2002/12/18 | Control Supplement | 020636 | 017 | AP | 2002/03/27 | Accelerated Approval | 020636 | 016 | AP | 2002/12/31 | Labeling Revision | 020636 | 015 | AP | 2001/02/23 | Control Supplement | 020636 | 014 | AP | 2000/11/06 | Labeling Revision | 020636 | 013 | AP | 2000/08/10 | Labeling Revision | 020636 | 012 | AP | 1999/08/05 | Manufacturing Change or Addition | 020636 | 011 | AP | 1999/10/25 | Labeling Revision | 020636 | 010 | AP | 1999/06/01 | Manufacturing Change or Addition | 020636 | 009 | AP | 1998/09/11 | New or Modified Indication | 020636 | 007 | AP | 1998/05/20 | Labeling Revision | 020636 | 005 | AP | 1997/09/19 | Package Change | 020636 | 004 | AP | 1997/09/24 | Control Supplement | 020636 | 003 | AP | 1998/01/16 | Control Supplement | 020636 | 002 | AP | 1998/05/20 | New or Modified Indication | 020636 | 001 | AP | 1997/11/21 | Control Supplement | 020636 | 000 | AP | 1996/06/21 | Approval |
|